Osteopore (OSX) Stock Overview
A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
OSX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Osteopore Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.011 |
| 52 Week High | AU$0.048 |
| 52 Week Low | AU$0.008 |
| Beta | -0.33 |
| 1 Month Change | -8.33% |
| 3 Month Change | -8.33% |
| 1 Year Change | -72.50% |
| 3 Year Change | -99.63% |
| 5 Year Change | -99.87% |
| Change since IPO | -99.90% |
Recent News & Updates
Shareholder Returns
| OSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | -1.5% |
| 1Y | -72.5% | 4.2% | 9.4% |
Return vs Industry: OSX underperformed the Australian Medical Equipment industry which returned 3.9% over the past year.
Return vs Market: OSX underperformed the Australian Market which returned 8.9% over the past year.
Price Volatility
| OSX volatility | |
|---|---|
| OSX Average Weekly Movement | 15.6% |
| Medical Equipment Industry Average Movement | 10.8% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 20.2% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: OSX's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: OSX's weekly volatility has decreased from 23% to 16% over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Yujing Lim | www.osteopore.com |
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
Osteopore Limited Fundamentals Summary
| OSX fundamental statistics | |
|---|---|
| Market cap | AU$2.61m |
| Earnings (TTM) | -AU$3.36m |
| Revenue (TTM) | AU$2.85m |
Is OSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSX income statement (TTM) | |
|---|---|
| Revenue | AU$2.85m |
| Cost of Revenue | AU$620.35k |
| Gross Profit | AU$2.23m |
| Other Expenses | AU$5.59m |
| Earnings | -AU$3.36m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 78.20% |
| Net Profit Margin | -118.22% |
| Debt/Equity Ratio | -361.9% |
How did OSX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 01:51 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Osteopore Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.